Traynor Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-6,219
Closed -$421K 169
2019
Q2
$421K Sell
6,219
-2,053
-25% -$135K 0.14% 97
2019
Q1
$537K Sell
8,272
-4,371
-35% -$291K 0.18% 84
2018
Q4
$790K Buy
12,643
+103
+0.8% +$7.2K 0.33% 56
2018
Q3
$968K Sell
12,540
-1,693
-12% -$128K 0.31% 57
2018
Q2
$1.01M Sell
14,233
-10,812
-43% -$764K 0.37% 50
2018
Q1
$1.89M Buy
25,045
+644
+3% +$51.2K 0.77% 30
2017
Q4
$1.75M Sell
24,401
-3,889
-14% -$295K 0.75% 32
2017
Q3
$2.29M Buy
28,290
+3,210
+13% +$245K 1.09% 21
2017
Q2
$1.87M Sell
25,080
-5,686
-18% -$378K 0.92% 24
2017
Q1
$2.31M Buy
30,766
+8,737
+40% +$614K 1.29% 16
2016
Q4
$1.57M Sell
22,029
-292
-1% -$21.7K 1.04% 24
2016
Q3
$1.64M Buy
22,321
+1,946
+10% +$158K 1.16% 22
2016
Q2
$1.71M Buy
20,375
+1,357
+7% +$120K 1.34% 18
2016
Q1
$1.75M Sell
19,018
-344
-2% -$31K 1.39% 19
2015
Q4
$1.96M Buy
19,362
+2,691
+16% +$280K 1.41% 19
2015
Q3
$1.64M Sell
16,671
-403
-2% -$44.8K 1.41% 14
2015
Q2
$2M Sell
17,074
-547
-3% -$59.8K 1.67% 10
2015
Q1
$1.73M Buy
17,621
+1,282
+8% +$130K 1.66% 10
2014
Q4
$1.54M Buy
+16,339
New +$1.69M 1.79% 9

Other funds holding GILD

Traynor Capital Management's GILD Position: Q3 2019 in Review

Traynor Capital Management sold out of Gilead Sciences (GILD) in Q3 2019, closing a stake of 6,219 shares — an estimated $421K sold.

Traynor Capital Management first reported a position in GILD in Q4 2014 and held it in 19 quarters. The position peaked at $2.31M in Q1 2017. 1,462 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • Traynor Capital Management reported no remaining Gilead Sciences position as of Q3 2019 after selling out during the quarter.
  • Traynor Capital Management sold 6,219 Gilead Sciences shares in Q3 2019, an estimated $421K.
  • Traynor Capital Management first reported a position in Gilead Sciences in Q4 2014 and held it in 19 quarters.
  • Traynor Capital Management's Gilead Sciences position peaked at $2.31M in Q1 2017.
  • 1,462 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Traynor Capital Management's 13F filing for Q3 2019, filed 1 Nov 2019.